MSN Labs launched cheapest COVID-19 medicine
August 14, 2020
MSN Group introduced the rollout of the most inexpensive Covid-19 treatment drug Favipiravir 200 mg at ₹33 in step with pill beneath the Favilow logo.
Jenburkt Pharmaceuticals’ Favivent become hitherto the cheapest Favipiravir 200mg providing in the market at ₹39 in line with pill. While Glenmark’s Favipriavir offering Fabiflu was released at ₹103 in step with the pill and later reduced to ₹75 consistent with pill, Cipla’s Ciplenza charges ₹68, Hetero Labs’ Favivir and Brinton Pharma’s Faviton are priced at ₹59.
The Hyderabad-based employer said it’s also gearing up to release Favipiravir 400mg inside the market quickly. The active pharmaceutical aspect (API) and the formulation for Favilow were evolved in-house via its R&D crew.
MSN Group CMD Dr MSN Reddy said, “We as an organization always accept as true with that first-class medicinal drug must be available and available to everyone”.